Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 68,600 shares, an increase of 25.4% from the February 28th total of 54,700 shares. Based on an average daily trading volume, of 94,300 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.0% of the company’s stock are short sold.
Sandoz Group Stock Down 2.2 %
Shares of SDZNY stock opened at $41.00 on Wednesday. Sandoz Group has a one year low of $27.79 and a one year high of $49.81. The company’s 50-day simple moving average is $45.27 and its 200-day simple moving average is $43.87.
Wall Street Analyst Weigh In
Separately, UBS Group lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 3rd.
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Stories
- Five stocks we like better than Sandoz Group
- How to Calculate Inflation Rate
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is a Death Cross in Stocks?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
